Zurich-based Rivia raises €13 million to power complex clinical trials with its agentic data engine

Rivia, a Zurich-based startup specialising in AI-driven analytics and clinical trial data infrastructure for BioTechs, today announced a €13 million ($15 million) Series A to accelerate team growth, scale agentic product development, and expand its international presence, especially in the US. The round was led by Earlybird, with participation from Defiant and existing investors Speedinvest, […] The post Zurich-based Rivia raises €13 million to power complex clinical trials with its agentic data engine appeared first on EU-Startups.